|
|
|
Date: |
|
Jun 29, 2012
|
|
News Title: |
|
Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment
|
|
Source: |
|
University of Colorado Denver
|
|
City: |
|
/
|
|
Country: |
|
United States
|
|
Categories: |
|
Cancer Biology
|
|
News Profile: |
Many lung cancers are driven by mutations in the epidermal growth-factor receptor (EGFR), and so it makes sense that many successful modern treatments block EGFR activity. Unfortunately, cancers inevitably evolve around EGFR inhibition, and patients with lung cancers eventually relapse.......> Full story
|